4 hours Nuvation Bio (NYSE:NUVB) Receives “Outperform” Rating from WedbushMarketBeat
Wedbush reaffirmed an “outperform” rating and set a $5.00 price target on shares of Nuvation Bio in a research note on Tuesday.
XWedbush reaffirmed an “outperform” rating and set a $5.00 price target on shares of Nuvation Bio in a research note on Tuesday.
X